Generation of neural cells using iPSCs from sleep bruxism patients with 5-HT2A polymorphism

Mayer, 2016, Sleep bruxism in respiratory medicine practice, Chest, 149, 262, 10.1378/chest.15-0822 Manfredini, 2010, Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol, 109, e26, 10.1016/j.tripleo.2010.02.013 Kato, 2003, Topical review: sleep bruxism and the role of peripheral sensory influences, J Orofac Pain, 17, 191 Lavigne, 2008, Bruxism physiology and pathology: an overview for clinicians, J Oral Rehabil, 35, 476, 10.1111/j.1365-2842.2008.01881.x Ellison, 1993, SSRI-associated nocturnal bruxism in four patients, J Clin Psychiatry, 54, 432 Gerber, 1998, Selective serotonin-reuptake inhibitor-induced movement disorders, Ann Pharmacother, 32, 692, 10.1345/aph.17302 Bostwick, 1999, Buspirone as an antidote to SSRI-induced bruxism in 4 cases, J Clin Psychiatry, 60, 857, 10.4088/JCP.v60n1209 Carra, 2010, Clonidine has a paradoxical effect on cyclic arousal and sleep bruxism during NREM sleep, Sleep, 33, 1711, 10.1093/sleep/33.12.1711 Rintakoski, 2012, Genetic factors account for half of the phenotypic variance in liability to sleep-related bruxism in young adults: a nationwide Finnish twin cohort study, Twin Res Hum Genet, 15, 714, 10.1017/thg.2012.54 Holmes, 1967, The social readjustment rating scale, J Psychosom Res, 11, 213, 10.1016/0022-3999(67)90010-4 Ohayon, 2001, Risk factors for sleep bruxism in the general population, Chest, 119, 53, 10.1378/chest.119.1.53 Abe, 2012, Association of genetic, psychological and behavioral factors with sleep bruxism in a Japanese population, J Sleep Res, 21, 289, 10.1111/j.1365-2869.2011.00961.x Koumegawa, 1991, Anemia in new congenital adult type polycystic kidney mice, J Urol, 146, 1645, 10.1016/S0022-5347(17)38204-6 Meltzer, 1999, The role of serotonin in antipsychotic drug action, Neuropsychopharmacology, 21, 106S, 10.1016/S0893-133X(99)00046-9 Aghajanian, 1999, Serotonin and hallucinogens, Neuropsychopharmacology, 21, 16S, 10.1016/S0893-133X(98)00135-3 Hrdina, 1997, Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment, Psychiatry Res, 66, 73, 10.1016/S0165-1781(96)03046-6 Burnet, 1996, 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia, Neuropsychopharmacology, 15, 442, 10.1016/S0893-133X(96)00053-X Saiz, 2008, Association between the A-1438G polymorphism of the serotonin 2A receptor gene and nonimpulsive suicide attempts, Psychiatr Genet, 18, 213, 10.1097/YPG.0b013e3283050ada Inayama, 1996, Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia, Am J Med Genet, 67, 103, 10.1002/(SICI)1096-8628(19960216)67:1<103::AID-AJMG18>3.0.CO;2-S Williams, 1997, Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia. EMASS Collaborative Group. European Multicentre Association Study of Schizophrenia, Lancet, 349, 1221, 10.1016/S0140-6736(05)62413-0 Holmes, 1998, 5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer’s disease, Hum Mol Genet, 7, 1507, 10.1093/hmg/7.9.1507 Arias, 2001, Variability in the 5-HT(2A) receptor gene is associated with seasonal pattern in major depression, Mol Psychiatry, 6, 239, 10.1038/sj.mp.4000818 Xu, 2014, A systematic review and meta-analysis of the association between serotonergic gene polymorphisms and obstructive sleep apnea syndrome, PLoS One, 9, e86460, 10.1371/journal.pone.0086460 Turecki, 1999, Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide, Am J Psychiatry, 156, 1456, 10.1176/ajp.156.9.1456 Parsons, 2004, The −1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity, Biol Psychiatry, 56, 406, 10.1016/j.biopsych.2004.06.020 Abdolmaleky, 2011, Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder, Schizophr Res, 129, 183, 10.1016/j.schres.2011.04.007 Smith, 2008, Genetic evaluation of the serotonergic system in chronic fatigue syndrome, Psychoneuroendocrinology, 33, 188, 10.1016/j.psyneuen.2007.11.001 Bray, 2004, The serotonin-2A receptor gene locus does not contain common polymorphism affecting mRNA levels in adult brain, Mol Psychiatry, 9, 109, 10.1038/sj.mp.4001366 Fukuda, 2006, Monoallelic and unequal allelic expression of the HTR2A gene in human brain and peripheral lymphocytes, Biol Psychiatry, 60, 1331, 10.1016/j.biopsych.2006.06.024 Smith, 2013, Multiple regulatory variants modulate expression of 5-hydroxytryptamine 2A receptors in human cortex, Biol Psychiatry, 73, 546, 10.1016/j.biopsych.2012.09.028 Mattis, 2011, Induced pluripotent stem cells: a new revolution for clinical neurology, Lancet Neurol, 10, 383, 10.1016/S1474-4422(11)70022-9 Marchetto, 2012, Modeling brain disease in a dish: really, Cell Stem Cell, 10, 642, 10.1016/j.stem.2012.05.008 Dimos, 2008, Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons, Science, 321, 1218, 10.1126/science.1158799 Okano, 2014, iPS cell technologies: significance and applications to CNS regeneration and disease, Mol Brain, 7, 22, 10.1186/1756-6606-7-22 Higurashi, 2013, A human Dravet syndrome model from patient induced pluripotent stem cells, Mol Brain, 6, 19, 10.1186/1756-6606-6-19 Imaizumi, 2012, Mitochondrial dysfunction associated with increased oxidative stress and alpha-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue, Mol Brain, 5, 35, 10.1186/1756-6606-5-35 Andoh-Noda, 2015, Differentiation of multipotent neural stem cells derived from Rett syndrome patients is biased toward the astrocytic lineage, Mol Brain, 8, 31, 10.1186/s13041-015-0121-2 Dube, 2004, Quantitative polygraphic controlled study on efficacy and safety of oral splint devices in tooth-grinding subjects, J Dent Res, 83, 398, 10.1177/154405910408300509 Rompre, 2007, Identification of a sleep bruxism subgroup with a higher risk of pain, J Dent Res, 86, 837, 10.1177/154405910708600906 Okita, 2011, A more efficient method to generate integration-free human iPS cells, Nat Methods, 8, 409, 10.1038/nmeth.1591 Okita, 2013, An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells, Stem Cells, 31, 458, 10.1002/stem.1293 Imaizumi, 2015, Controlling the regional identity of hPSC-derived neurons to uncover neuronal subtype specificity of neurological disease phenotypes, Stem Cell Rep, 5, 1010, 10.1016/j.stemcr.2015.10.005 Okada, 2004, Retinoic-acid-concentration-dependent acquisition of neural cell identity during in vitro differentiation of mouse embryonic stem cells, Dev Biol, 275, 124, 10.1016/j.ydbio.2004.07.038 Shimazaki, 2001, The ciliary neurotrophic factor/leukemia inhibitory factor/gp130 receptor complex operates in the maintenance of mammalian forebrain neural stem cells, J Neurosci, 21, 7642, 10.1523/JNEUROSCI.21-19-07642.2001 Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019 Guiard, 2015, Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link?, Front Pharmacol, 6, 46, 10.3389/fphar.2015.00046 van der Zaag, 2005, Controlled assessment of the efficacy of occlusal stabilization splints on sleep bruxism, J Orofac Pain, 19, 151 Park, 2008, Disease-specific induced pluripotent stem cells, Cell, 134, 877, 10.1016/j.cell.2008.07.041 Robinton, 2012, The promise of induced pluripotent stem cells in research and therapy, Nature, 481, 295, 10.1038/nature10761 Bellin, 2012, Induced pluripotent stem cells: the new patient, Nat Rev Mol Cell Biol, 13, 713, 10.1038/nrm3448 Imaizumi, 2014, Modeling human neurological disorders with induced pluripotent stem cells, J Neurochem, 129, 388, 10.1111/jnc.12625 Sugiura, 2014, Induced pluripotent stem cell generation-associated point mutations arise during the initial stages of the conversion of these cells, Stem Cell Rep, 2, 52, 10.1016/j.stemcr.2013.11.006 Hotta, 2015, From genomics to gene therapy: induced pluripotent stem cells meet genome editing, Annu Rev Genet, 49, 47, 10.1146/annurev-genet-112414-054926